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Abstract
Objectives To undertake cross-cultural adaptation and
validation of the educational needs assessment tool
(ENAT) for use with people with rheumatoid arthritis (RA)
and systemic sclerosis (SSc) in Poland.
Methods The study involved two main phases: (1) cross-
cultural adaptation of the ENAT from English into Polish
and (2) Cross-cultural validation of Polish Educational
Needs Assessment Tool (Pol-ENAT). The first phase fol-
lowed an established process of cross-cultural adaptation of
self-report measures. The second phase involved comple-
tion of the Pol-ENAT by patients and subjecting the
data to Rasch analysis to assess the construct validity,
unidimensionality, internal consistency and cross-cultural
invariance.
Results An adequate conceptual equivalence was
achieved following the adaptation process. The dataset for
validation comprised a total of 278 patients, 237 (85.3 %) of
which were female. In each disease group (145, RA and
133, SSc), the 7 domains of the Pol-ENAT were found to fit
the Rasch model, X2(df) = 16.953(14), p = 0.259 and
8.132(14), p = 0.882 for RA and SSc, respectively. Internal
consistency of the Pol-ENAT was high (patient separation
index = 0.85 and 0.89 for SSc and RA, respectively), and
unidimensionality was confirmed. Cross-cultural differen-
tial item functioning (DIF) was detected in some subscales,
and DIF-adjusted conversion tables were calibrated to
enable cross-cultural comparison of data between Poland
and the UK.
Conclusion Using a standard process in cross-cultural
adaptation, conceptual equivalence was achieved between
the original (UK) ENAT and the adapted Pol-ENAT. Fit to
the Rasch model, confirmed that the construct validity,
unidimensionality and internal consistency of the ENAT
have been preserved.
Keywords Rheumatoid arthritis  Systemic sclerosis 
Patient education  Needs assessment  Cross-cultural
validation  Rasch analysis
Introduction
Rheumatoid arthritis (RA) is a systemic inflammatory
disease characterized by the presence of a destructive
polyarthritis with a predisposition for affecting the
peripheral joints [1]. Systemic sclerosis (SSc) is an auto-
immune connective tissue disease characterized by small-
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vessel vasculopathy, autoantibody production and exces-
sive collagen deposition in the skin and internal organs [2].
Both RA and SSc are chronic disabling diseases, which
have a negative impact on individuals’ physical, social and
psychological functioning [3–5].
People with RA and SSc have many and varied needs,
and so in addition to offering specific drug treatments and
therapies, patient education is recommended as an integral
part of the disease management [6]. Most patients with
rheumatic diseases believe in the value of patient education
and health professionals; especially, nurses spend a con-
siderable amount of their time in providing patient edu-
cation [7–9].
Patient education is an interactive process between
patients and health professionals aimed at supporting and
enabling patients to manage their life with arthritis and
optimizing their health and well-being [10]. The effects of
patient education can be difficult to demonstrate in ran-
domized controlled trials although there is growing evi-
dence that patients’ needs and individual learning
capabilities play an important role [9–12]. In chronic dis-
eases, patients’ perspective of their educational needs is
important since they have experiential knowledge about
their disease and they undertake daily self-care activities.
Patients’ expectations determine whether patient education
is likely to lead to behavioural change [13]; therefore, it is
extremely important for health professionals to assess
patient’s educational needs and priorities before providing
education. This assessment will help tailor education to
meet patient’s priorities and promote shared decision-
making.
Although it is widely accepted that effective patient
education has to be targeted to meet the patient’s needs and
expectations [14–16], our literature search found only one
tool for assessing educational needs of patients with
rheumatic diseases: the educational needs assessment
tool—ENAT [17], which was developed in the UK. The
tool has been adapted into other eight European languages
(Austrian German, Dutch, Italian, Finnish, Norwegian,
Portuguese, Spanish and Swedish) and validated in RA,
SSc and other rheumatic conditions [18, 19], but there was
no Polish version of the questionnaire.
For a questionnaire to be used in two different cultures,
it must be shown to demonstrate conceptual and mea-
surement equivalence. Conceptual equivalence can be
defined as similarities in the way abstract, latent concepts
are interpreted among different cultural groups [20]. To
achieve this in the questionnaires adaptation, different
guidelines have been proposed, most of which involve a
rigorous iterative ‘forward–backward’ translation process,
review of the translations and testing on a sample of
patients [21–24]. Measurement equivalence is the compa-
rability of psychometric properties in the source and the
target (adapted) measures [25]. Questionnaire items do not
always function equally in different cultural groups, and an
item that behaves differently is said to exhibit a cross-
cultural bias or differential item function (DIF) with
respect to culture [26–28]. Since measurement equivalence
is the basic requirement for comparing data across cultural
groups, it is important to: (1) assess the construct validity
of the adapted questionnaire and (2) examine and account
for cross-cultural bias in the translated questionnaire [26,
28]. Rasch analysis is the method by which both construct
validity and cross-cultural DIF can be assessed [27–29].
The aim of this study was to undertake a cross-cultural
adaptation of the ENAT into Polish and then use Rasch
analysis to validate the adapted tool (Pol-ENAT) in RA and
Ssc.
Methods
Design
This was a cross-sectional study conducted in two phases:
(1) cross-cultural adaptation of the ENAT into Polish and
(2) validation of the adapted tools (Pol-ENAT) in RA and
SSc. The first (adaptation) phase followed standardized
guidelines for cross-cultural adaptation of patient-reported
outcome measures suggested by Beaton et al. [21]. The
second phase was conducted using a cross-sectional survey
design requiring patient completion of the adapted versions
of the ENAT on one occasion, then subjecting the data to
Rasch analysis to assess the construct validity, reliability
and cross-cultural invariance of the translated tools. Ethical
approval was obtained from the local ethics committee.
Measures
The ENAT is a simple patient-completed questionnaire,
which comprises 39 items grouped into the following 7
domains: managing pain (6 items), movement (5 items),
feelings (4 items), arthritis process (7 items), treatments
(7 items), self-help measures (6 items) and support systems
(4 items). Items are Likert scales ranging from 0—‘‘not
important at all’’ to 4—‘‘extremely important’’. The ENAT
is used as a ‘generic’ tool across rheumatic diseases but the
term ‘arthritis’ is replaced by ‘rheumatic disease’ when
used in SSc. The descriptions of how the ENAT is used and
scored are given in the online supplementary material.
Phase 1: Cross-cultural adaptation
The original (English) ENAT was translated into Polish
using the cross-cultural adaptation process described by
Beaton et al. [21]. The process comprises five stages:
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Forward translation, synthesis of the translations, back-
translation, expert committee assessment and field testing.
The first (forward) translation stage from English (source
language) into Polish (target language) was carried out by
two independent translators whose mother tongue was Pol-
ish. The first translator was a professional bilingual trans-
lator (SS), and the second was a bilingual lay person (TS).
Each translator produced a written report, (T1 and T2) of his
translation, highlighting difficult phrases or uncertainties
along with the rationale for their word choices.
A third unbiased person was added to the team (JS),
whose role was to serve as a mediator in the discussion of
translation differences arising from T1 and T2. Working
from the original questionnaire as well as from the first
(T1) and the second translator’s (T2) version, one common
translation (T-12) was produced together with a report
documenting the process and how issues were resolved.
Back-translation stage was undertaken by two bilingual
‘back-translators’ (MK and PD) whose mother tongue was
English and totally blind to the original versions. They
worked from the T-12 version of the ENAT, producing
English translations (BT1 and BT2). This is a process of
validity checking to ensure the translated version accu-
rately reflects the item content of the original version.
The composition of the expert committee included a
methodologist, health professionals, all the (forward and
backward) translators and the translation synthesis recor-
der. The original developer of the questionnaire was also
included. The expert committee consolidated all the ver-
sions and components of the questionnaire and all trans-
lated versions (T1, T2, T12, BT1, BT2), discussing
discrepancies raised in previous stages, and a consensus
was reached on all items. The prefinal version of the ENAT
was produced for field testing.
The field test of the adapted ENAT comprised 30
patients (15 with RA and 15 with SSc) recruited from the
rheumatology outpatient clinics at one of the recruiting
centres. They completed the Pol-ENAT unaided; then, they
were interviewed to probe what they thought was meant by
each questionnaire item and their response. Both the
meaning of the items and responses were explored. A
summary of issues raised in the translation for each item is
presented in Table 2.
Phase 2: Cross-cultural validation
The final translated versions of the ENAT (for RA and
SSc) were then completed by a consecutive sample of
patients fulfilling the above-mentioned inclusion criteria.
The ENATs were anonymous but contained patients’
demographical data such as gender, age, educational
background and self-reported disease duration. Once
completed, the data were entered into an IBM SPSS
database (version 19) [30] and subsequently subjected to
Rasch analysis RUMM2030 software [31].
Participants
Patients were recruited from rheumatology outpatient
clinics at seven rheumatology centres in Poland. The
inclusion criteria were: (1) positive diagnosis of either RA
(using the ACR and the ACR/EULAR classification criteria
for [32, 33]) or SSc (2) aged 18 years or above and
(3) willingness to complete and return a questionnaire. The
exclusion criteria were: (1) inability to complete the ENAT
unaided and (2) having more than one form of rheumatic
disease. The patients in the SSc group had articular
symptoms such as pain, stiffness and movement impair-
ment. Matching datasets of patients with RA and SSc from
the UK were used in the analysis stage to test the cross-
cultural invariance. This would inform whether the ENAT
works in the same manner when completed by patients
with the same disease in English or in Polish (the adapted
version).
Data analysis
Since the original (English) ENAT and other language
versions have been shown to fit the Rasch model after
correction for local dependency [18, 19], we used Rasch
analysis in this study to test whether Pol-ENAT had
retained its psychometric properties following the adapta-
tion process. For this analysis, we used the Master’s Partial
Credit Model parameterization [34] in RUM2030 software
[31]. Each Pol-ENAT item was assessed for ‘fit’ to the
Rasch model, and then, the scale was assessed as a 39-item
construct and as a 7-domain construct. In addition to fit
statistics, the scales were tested for internal consistency,
unidimensionality and DIF. The expected values for perfect
model fit are presented at the bottom of tables of results.
DIF analysis can be carried out efficiently along with other
psychometric tests within the framework of Rasch models.
Rasch analysis was used to test the evidence of cross-cul-
tural DIF, to quantify the DIF and to calibrate a DIF-
adjusted interval-level scale [27, 35]. Where cross-cultural
DIF (between the Polish and UK datasets) was found, a
DIF-adjusted scale was calibrated for use when data
pooling from the two countries is desired.
Results
Patient characteristics
The validation study sample comprised 278 patients with
RA (n = 145) and SSc (n = 133). Their mean (SD) age,
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disease duration and gender distribution are summarized in
Table 1. The cross-cultural validation phase included
comparison of datasets of UK patients with RA and SSc,
and their patient characteristics are also summarized in
Table 1.
Adaptation into Polish
Issues around translation included: multiple meanings of
certain concepts, grammatical difficulties and inexactness
or idiomatic expressions. Other issues were due to differ-
ences in the style of formulating questionnaire items in
English and in Polish. The translators and the expert
committee solved all the above problems by finding Polish
equivalents, which would be understandable but also
accurate from a medical point of view. A summary of
issues arising from the back-translations and the agree-
ments for each ENAT item (for RA) are presented in
Table 2. The Expert Committee believes that the aim of
proposing an accurate Polish version of the ENAT has been
achieved.
Cross-cultural validation phase
Table 3 presents fit statistics for individual items and for
each subscale, i.e. pain, movement and feelings. A signif-
icant chi-square probability suggests a departure from the
model. Most items in both the RA and SSc datasets were
found to fit the model.
Despite the generally good individual item fit within
each of the domains, when the scale is assessed as a sin-
gular 39-item construct, the model fit suggests significant
deviation from the Rasch model (Table 4, analysis 1).
Further investigation revealed the major cause of this misfit
to be multiple significant residual correlations between
items, therefore indicating local dependency. The pattern
of the residual correlations suggested that the dependency
clustered within each of the separate domains; therefore,
the items were grouped within their respective domains and
treated as domain-level items (or testlets). This approach
corrected for the local dependency within the domains, and
subsequent analyses (Table 4, analysis 2 for the Polish, UK
and the pooled datasets) resulted into fit to the model and
satisfied the strict test for unidimensionality. The internal
consistency was above the value of 0.7, which is a required
value for group use [36].
Cross-cultural invariance
Polish Educational Needs Assessment Tool was invariant
to age, gender, disease duration and education background.
The pooled dataset for RA revealed a cross-cultural DIF
where Polish patients were more likely to have higher
scores on ‘pain’ and ‘disease process’ and lower scores on
‘treatments’ and ‘support’ than their UK counterparts. The
SSc-pooled datasets revealed cross-cultural DIF in only
one subscale—‘support’ where the Polish patients were
more likely to have higher scores than their UK counter-
parts. The cross-cultural DIF patterns and their significance
are presented in Fig. 1. This finding means that adjustment
for the cross-cultural bias is required if the data from
Poland are pooled or compared with the UK data.
The Pol-ENAT raw scores for each of the seven sub-
scales (which are ordinal in nature) were Rasch-trans-
formed to calibrate interval-level scales with which data
can be transformed. The conversion charts for the Polish
data (RA and SSc) are presented in the online supple-
mentary tables S1 and S2. Separate DIF-adjusted tables for
comparison between the UK and Polish data are presented
in online supplementary tables S3 and S4. The instruction
on how to use the conversion charts is given in the online
supplementary material.
Discussion
Patient education should be an integral part of the care of
people with rheumatic conditions [6, 10]. Our research has
provided a valid tool with which clinicians in Poland can
assess the educational needs of patients with RA and SSc.
This assessment is likely to lead to provision of targeted
and patient-centred education. When used for clinical
purposes, the Pol-ENAT does not need scoring as the cli-
nician can easily tell the items that are rated by the patient
as ‘extremely important’. However, when used as an out-
come measure, then the Pol-ENAT has satisfied psycho-
metric standards to enable meaningful summation of scores
within each domain. The tool has been found to have
sufficient cross-cultural validity to enable data pooling and
comparisons between Poland and the UK.
Although it is generally accepted that simple translation
of a questionnaire into another language is not appropriate,
Table 1 Patient characteristics
Poland UK
RA
(n = 145)
SSc
(n = 133)
RA
(n = 125)
SSc
(n = 128)
Mean age (SD) 52.79
(13.05)
53.89
(14.26)
56.26
(13.24)
54.44
(12.07)
Disease duration
(SD)
13.36
(9.84)
10.84
(10.34)
13.55
(9.52)
14.34
(11.49)
% Female 82.1 88.7 79.2 79.7
% Only basic
education
9.7 10.5
SD standard deviation, RA rheumatoid arthritis, SSc systemic sclerosis
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Table 2 Back-translation, issues and agreements for each ENAT item
Original Back-translation 1
(BT1)
Back-translation 2
(BT2)
Issues Agreement
Arthritis Educational
Needs Assessment Tool
‘‘Assessment Tools for
Educational Needs of
Patients with Arthritis’’
‘‘A tool for assessing
educational needs of
patients with arthritis
related’’
Uncertainty word whether
‘‘tools’’ or ‘‘tool’’ should
in be used in Polish
version
Discussion on the Polish
multiple meaning of
word ‘‘arthritis’’
Also, there were
differences in translation
of the term ‘‘arthritis’’
‘‘Narze˛dzie do oceny potrzeb
edukacyjnych pacjento´w
zwia˛zanych z zapaleniem
stawo´w’’
The chosen term ‘‘zapalenie
stawo´w’’ is the most
adequate translation.
How long have you had
your arthritis for?
‘‘How long have you had
arthritis?’’
‘‘How long have you
suffered from
arthritis?’’
Uncertainty whether word
‘‘suffer’’ is appropriate
‘‘Jak długo choruje Pani/Pan
na zapalenie stawo´w ?’’
The Polish translation is
correct in terms of style.
Please state your age in
years:
‘‘Please state your age’’ ‘‘Please state your age’’ Discussion whether phrase
‘‘in years’’ should be
added
‘‘Prosze˛ podac´ swo´j wiek.’’
The phrase ‘‘in years’’ has
been omitted.
How old were you when
you left school?
‘‘How old were you when
you finished with
formal education?’’
‘‘How old were you
when you finished
school education?’’
Customary question
concerning education in
Polish does not require
information about age
‘‘Prosze˛ podac´ swoje
wykształcenie.’’
The most correct Polish
phrase has been chosen.
At this time, do you want
education about anything
to help you deal with
your arthritis?
Would you currently like
to receive information
which will help you
manage your arthritis?
Are you interested in
getting information
that will help you cope
with arthritis?
Uncertainty how to
translate into Polish
‘‘manage’’, ‘‘cope with’’
and ‘‘education’’
‘‘Czy obecnie chciałaby
Pani/Pan zdobyc´
informacje kto´re pomoga˛
Pani/Panu radzic´ sobie z
zapaleniem stawo´w?’’
Polish translation is correct
in terms of style and
grammar.
If yes, what? ‘‘If yes, what information
would you like to
receive?’’
‘‘If so, what would you
like to know?’’
More formally correct
version of question in
Polish should be given
‘‘Jes´li tak, to czego chciałaby
Pani/Pan sie˛ dowiedziec´?’’
Polish version is correct in
terms of style.
In general, how much
information do you want
about your arthritis?
‘‘In general, how much
would you like to know
about your rheumatic
disease?’’
‘‘Generally speaking,
how much would you
like to know about
your rheumatism?’’
Discussion on word choice
between ‘‘rheumatic
disease’’ and
‘‘rheumatism’’
‘‘Ogo´lnie rzecz biora˛c, jak
du _zo chciałaby sie˛ Pani/
Pan dowiedziec´ o swojej
chorobie reumatycznej?’’
Polish version applies the
term ‘‘rheumathic disease’’
How much do you need to
know now about each of
the following things?
Please tick in the column
that shows best how you
feel:
‘‘How much would you
like to know right now
about the following
issues? Please mark the
appropriate column
with an ‘X’’’
‘‘How much would you/
you already know
about the following
issues? Please place a
cross in the
appropriate column’’
Discussion concerning the
phrase ‘‘please place a
cross in the appropriate
column’’
‘‘Jak wiele chciałaby Pani/
Pan wiedziec´ ju _z teraz na
temat naste˛puja˛cych
zagadnien´? Prosze˛ o
postawienie krzy _zyka w
odpowiedniej kolumnie.’’
The most adequate Polish
equivalent has been
chosen.
This section relates to
managing pain
‘‘Section on managing
pain’’
‘‘The section on coping
with pain’’
Discussion whether to
choose less or more
formal way of
introducing a new section
of questions
‘‘Sekcja dotycza˛ca radzenie
sobie z bo´lem.’’
A more formal way of
introducing a new section
has been chosen.
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Table 2 continued
Original Back-translation 1
(BT1)
Back-translation 2
(BT2)
Issues Agreement
How important is it for you
to know more about the
following:
How important is
knowing more about the
following issues for
you?
How important is it for
you/you would know
more about the
following issues?
Discussion wether choose
less or more formal way
of asking a question
‘‘Jak wa _zne jest dla Pani/
Pana by wiedziec´ wie˛cej o
naste˛puja˛cych
zagadnieniach.’’
A formal way of asking a
question has been chosen.
Using exercise ‘‘Gymnastic exercise’’ ‘‘Physical exercises’’ Uncertainty whether
‘‘gymnastic’’ and
‘‘physical’’ can be used
synonymic
‘‘C´wiczenia gimnastyczne’’
Polish version is correct in
terms of style.
This section relates to
movement
‘‘Section on issues related
to moving around’’
‘‘The section on issues
related to mobility’’
Discussion whether to
choose less or more
formal way of
introducing a new section
of questions
‘‘Sekcja dotycza˛ca zagadnien´
zwia˛zanych z poruszaniem
sie˛.’’
The most adequate Polish
version has been chosen
Ways to do things which
wear my joints less
‘‘Methods of reducing
wear of/relieving
joints’’
‘‘Methods of relieving
joints’’
English idiomatic
expression ‘‘wear joints
less’’ was replaced with a
Polish idiomatic phrase
‘‘oszcze˛dzac´ satwy’’ (In
English: save)
‘‘Metody oszcze˛dzania/
odcia˛ _zania stawo´w’’
Ways to deal with moods
or depression
‘‘Methods to help manage
mood changes or
depressive states’’
‘‘Ways to cope with
moods or periods of
depression’’
Ambiguous meaning of a
term ‘‘moods’’
‘‘Sponsor radzenia sobie ze
zmiennos´cia˛ nastrojo´w lub
stanami depresji.’’
The chosen term ,,zmiennos´c´
nastrojo´w’’ means frequent
changes in mood
Why I am feeling down or
depressed
‘‘Why do I feel down or
depressed?’’
‘‘Why do I feel moody
or depresses?’’
Ambiguous meaning of the
term ‘‘be depressed’’
‘‘Dlaczego czuja˛
sie˛ przygne˛biona/y, czy
depresyjna/y’’
The chosen term
,,depresyjny’’ relates to a
state of depression.
How arthritis might affect
my children or relatives
‘‘Can the disease have an
effect on the lives of my
children and close
ones?’’
‘‘Can the disease affect
the lives of my
children and family?’’
Multiple meaning of word
‘‘affect’’
‘‘Czy choroba mo _ze miec´
wpływ na _zycie moich
dzieci i bliskich?’’
The chosen phrase ,,wpływ
na _zycie’’ relates to quality
of life
What might happen in the
future
‘‘How will my condition
change in the future?’’
‘‘How will my condition
change in the future?’’
The question is open to
various interpretations
‘‘Jak mo´j stan be˛dzie sie˛
zmieniał w przyszłos´ci?’’
The translation focuses on
patient’s personal
condition in the future
This section is about
treatments you may be
receiving from health
professionals
‘‘Section on methods of
treatment that you can
receive from nurses and
other medical
professionals’’
‘‘The section concerns
treatments that the
patient can receive
from nurses and other
health care workers’’
Lack of a Polish equivalent
of a term ‘‘health
professionals’’
‘‘Secant dotycza˛ca sposobo´w
leczenia, kto´re Pani/Pan
mo _ze otrzymac´ od
piele˛gniarki i innych
pracowniko´w ochrony
zdrowia.’’
The chosen phrase describes
the meaning of ‘‘health
professionals’’
Qual Life Res
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Table 2 continued
Original Back-translation 1
(BT1)
Back-translation 2
(BT2)
Issues Agreement
How an operation might
help me
‘‘Can surgery help me?’’ ‘‘Can surgery help me?’’ Uncertainty whether word
‘‘surgery’’ or ‘‘operation’’
should be used
‘‘Czy zabieg chirurgiczny
mo _ze mi pomo´c?’’
The most adequate Polish
term has been chosen.
What the side effects of
my medicines are
‘‘What are adverse side
effects of medicines?’’
‘‘Are there side effects
to the medication?’’
Uncertainty whether the
question should be more
general or relate to
condition of the
particular patient
‘‘Jakie sa˛ działanie
niepo _za˛dane leko´w kto´re
przyjmuje˛?’’
The chosen phrase relates to
patient’s condition.
How appliances might
help me (splints,
adaptations, collars)
‘‘What devices may help
me (orthopaedic collars,
splints, stabilizers)?’’
‘‘What appliances can
help me (e.g.
orthopaedic collars,
splints, stabilizers)?’’
Difficulty with translating
term ‘‘adaptations’’
‘‘Jakie przyrza˛dy i/lub
udogodnienia moga˛ mi
pomo´c (np. kołnierze
ortopedyczne, szyny,
specjalnie dostosowane
pore˛cze, etc.)?’’
A descriptive phrase
explaining the term
‘‘adaptation’’ has been
chosen
Foods or vitamins that
might help
‘‘Diet or vitamins which
may help’’
‘‘Diet or vitamins that
may help’’
Uncertainty whether
‘‘foods’’ relates to ‘‘diet’’
‘‘Produkty pokarmowe lub
witaminy kto´re moga˛
pomo´c’’
The chosen term ‘‘produkty
pokarmowe’’ means foods
Exercises I should be
doing
‘‘Recommended motion
exercises’’
‘‘Recommended
physical exercises’’
Uncertainty whether word
‘‘recommended’’ should
be used
‘‘Zalecane c´wiczenia’’
The most adequate Polish
translation has been chosen
How much exercise I
should be doing
‘‘Frequency of
performing motion
exercises’’
‘‘The frequency of
physical exercises’’
Uncertainty whether the
word ‘‘frequency’’ is
adequate
‘‘Cze˛stotliwos´c´
wykonywania c´wiczen´
ruchowych’’
The chosen term
‘‘cze˛stotliwos´c´’’ means
frequency
Times when I should call
the doctor or nurse
‘‘Situations when I should
contact a doctor or
nurse’’
‘‘In what situations,
should I consult a
doctor or nurse?’’
Uncertainty whether
‘‘situations’’ is the
correct translation of the
word ‘‘times’’
‘‘Sytuacje w kto´rych
powinnam/nienem
skontaktowac´ sie˛ z
lekarzem lub
piele˛gniarka˛?’’
Polish translation is correct
in terms of grammar and
style
Organizations I can get in
touch with about arthritis
‘‘Organizations which can
help patients with
rheumatic diseases?’’
‘‘Organizations that can
help patients with
rheumatic diseases’’
Ambiguous meaning of
term ‘‘organization’’
also there is an ambiguous
meaning of idiomatic
expression ‘‘get in touch
with.’’
‘‘Stowarzyszenia kto´re moga˛
pomo´c pacjentom z
chorobami
reumatycznymi.’’
Polish phrase describing
contacting an organist has
been chosen
Who I can ask about
financial help
‘‘Who can I ask for
financial help?’’
‘‘Who can I ask about
financial assistance?’’
Lack of cultural
equivalence (it is not
possible to ask for
financial help in case of
suffering from arthritis)
‘‘Kogo moge˛ poprosic´ o
pomoc finansowa˛?’’
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Table 2 continued
Original Back-translation 1
(BT1)
Back-translation 2
(BT2)
Issues Agreement
Where I can find groups
who will help me to cope
with arthritis
‘‘Where can I find support
groups for people with
rheumatic diseases?’’
‘‘Where can I find
support groups for
people with rheumatic
diseases?’’
Uncertainty whether
‘‘groups’’ means the
same as ‘‘support
groups’’
‘‘Gdzie moge˛ znalez´c´ grupy
wsparcia dla oso´b z
chorobami reumatycznymi
?’’
The term related to help
groups has been used
How I can get the most out
of seeing the doctor or
nurse
‘‘How can I improve
communication with
doctors or nurses to
maximize
effectiveness?’’
‘‘How to make more
effective contacts with
a doctor or nurse?’’
Idiomatic expression ‘‘get
the most out of’’ can be
translated in various
ways in Polish
‘‘Jakeeeeeee sprawic´ by
kontakty z lekarzem lub
piele˛gniarka˛ były
najbardziej efektywne?’’
The word ‘‘efektywne’’ (in
English: effective) has
been used
Table 3 Fit statistics for individual items and subscales (testlets)
Items RA SSc
Loc SE FR DF v2 *P Loc SE FR DF v2 *P
Pain 1 -1.09 0.12 0.45 130.49 0.13 0.94 -0.84 0.11 -0.47 122.69 1.43 0.49
2 -0.01 0.10 1.15 130.49 0.79 0.67 -0.13 0.09 0.64 122.69 1.04 0.59
3 -0.20 0.10 0.80 130.49 3.66 0.16 0.10 0.09 -0.07 122.69 4.11 0.13
4 0.20 0.10 1.66 130.49 5.19 0.07 -0.03 0.09 1.00 122.69 0.64 0.73
5 -0.17 0.10 0.44 130.49 1.21 0.54 -0.21 0.09 1.64 122.69 7.99 0.02
6 0.13 0.09 3.58 130.49 4.27 0.12 0.02 0.09 2.71 122.69 12.27 0.00
Movement 7 0.71 0.10 4.86 130.49 30.85 0.00 0.65 0.08 2.13 122.69 2.81 0.25
8 0.76 0.10 1.71 130.49 8.48 0.01 0.57 0.08 1.09 122.69 1.41 0.50
9 0.22 0.10 2.47 130.49 6.17 0.05 0.49 0.09 0.92 122.69 0.08 0.96
10 0.16 0.10 0.97 130.49 1.29 0.52 0.15 0.09 -0.18 122.69 0.40 0.82
11 -0.76 0.12 -1.02 130.49 2.86 0.24 -0.08 0.08 -0.28 122.69 0.04 0.98
Feelings 12 -0.06 0.10 -0.33 130.49 2.86 0.24 0.09 0.09 0.13 122.69 0.65 0.72
13 0.31 0.10 0.03 130.49 1.87 0.39 0.17 0.08 1.80 122.69 0.61 0.74
14 0.10 0.10 -0.92 130.49 0.59 0.74 0.09 0.09 0.11 122.69 0.68 0.71
15 0.41 0.09 0.59 130.49 0.93 0.63 0.36 0.08 1.66 122.69 0.32 0.85
Disease 16 -0.27 0.09 3.91 130.49 8.56 0.01 -0.33 0.09 1.68 122.69 2.42 0.30
17 0.18 0.09 0.07 130.49 0.11 0.95 0.17 0.08 0.59 122.69 0.64 0.73
18 -0.32 0.09 -0.02 130.49 3.01 0.22 -0.32 0.08 1.54 122.69 0.15 0.93
19 -0.90 0.11 -0.82 130.49 1.36 0.51 -0.28 0.08 0.67 122.69 0.56 0.75
20 -0.27 0.10 -2.07 130.49 2.37 0.31 -0.11 0.08 -1.10 122.69 2.63 0.27
21 0.21 0.09 0.62 130.49 0.64 0.73 0.00 0.09 -1.45 122.69 6.23 0.04
22 -0.59 0.10 -0.19 130.49 0.38 0.83 -0.58 0.09 -0.53 122.69 1.83 0.40
Treatments 23 0.27 0.09 -0.57 130.49 4.65 0.10 0.09 0.09 0.81 122.69 0.93 0.63
24 -0.01 0.09 -0.39 130.49 1.95 0.38 0.06 0.08 -0.08 122.69 0.74 0.69
25 -0.42 0.09 -2.26 130.49 6.29 0.04 -0.21 0.09 0.93 122.69 2.26 0.32
26 0.22 0.09 -1.76 130.49 1.84 0.40 0.05 0.09 -0.17 122.69 0.42 0.81
27 0.17 0.09 -1.77 130.49 1.18 0.56 -0.01 0.09 -0.53 122.69 1.83 0.40
28 0.11 0.09 1.67 130.49 0.40 0.82 0.45 0.08 0.50 122.69 3.43 0.18
29 0.21 0.09 3.10 130.49 2.10 0.35 0.55 0.08 -0.04 122.69 0.25 0.88
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Table 3 continued
Items RA SSc
Loc SE FR DF v2 *P Loc SE FR DF v2 *P
Self-help 30 0.32 0.10 1.80 130.49 1.59 0.45 0.19 0.09 3.02 122.69 9.87 0.01
31 -0.28 0.10 -1.09 130.49 0.92 0.63 -0.33 0.10 0.48 122.69 0.16 0.92
32 -0.25 0.10 -2.06 130.49 7.26 0.03 -0.46 0.10 -1.18 122.69 6.68 0.04
33 -0.42 0.10 -1.93 130.49 8.24 0.02 -0.34 0.10 -1.17 122.69 6.02 0.05
34 -0.19 0.10 -2.30 130.49 8.88 0.01 -0.24 0.10 -0.89 122.69 8.40 0.02
35 0.05 0.09 -2.23 130.49 2.50 0.29 -0.27 0.09 -2.01 122.69 9.19 0.01
Support 36 0.28 0.10 0.88 130.49 2.48 0.29 0.07 0.09 0.54 122.69 0.83 0.66
37 0.42 0.09 -0.34 130.49 3.94 0.14 0.29 0.09 0.68 122.69 0.02 0.99
38 0.57 0.10 -1.28 130.49 4.53 0.10 0.33 0.09 -0.01 122.69 0.74 0.69
39 0.19 0.09 -1.90 130.49 4.95 0.08 -0.16 0.09 -0.98 122.69 3.85 0.15
Testlets
Pain -0.12 0.03 2.45 114.43 3.28 0.19 -0.09 0.02 0.02 107.57 0.61 0.74
Movements 0.11 0.03 1.20 114.43 1.88 0.39 0.12 0.02 1.47 107.57 0.58 0.75
Feelings 0.04 0.03 0.27 114.43 1.23 0.54 0.04 0.03 1.78 107.57 0.41 0.82
Disease -0.12 0.02 -0.36 114.43 0.26 0.88 -0.11 0.02 0.14 107.57 0.84 0.66
Treatments 0.00 0.02 -0.41 114.43 2.81 0.25 0.09 0.02 1.06 107.57 0.62 0.73
Self-help -0.07 0.03 -2.60 114.43 4.33 0.11 -0.08 0.02 -0.29 107.57 1.64 0.44
Support 0.15 0.03 -0.55 114.43 3.18 0.20 0.04 0.03 -0.40 107.57 3.44 0.18
Loc location, SE standard error, FR fit residuals, DF degrees of freedom, RA rheumatoid arthritis, SSc systemic sclerosis, v2 chi square
* Bonferroni adjusted p value [ 0.0013 for model fit (i.e. 0.05/39 tests) or p [ 0.0071 for subscale model fit (i.e. 0.05/7 tests)
Table 4 Fit statistics indicating item fit, person fit and unidimensionality of the 7-domain scales in SSc and RA disease groups
Disease group Country Analyses Item fit
residual
Person fit
residual
Chi-square interaction PSI Independent t tests
(95 % CI)
Mean SD Mean SD Value (df) p
SSc Poland Analysis 1 0.362 1.142 -0.411 2.312 104.562 (78) 0.024 0.947
Analysis 2 0.540 0.883 -0.329 1.233 8.132 (14) 0.882 0.855 0.046 (0.008, 0.083)
UK Analysis 1 0.319 1.524 -0.330 2.105 54.951 (39) 0.047 0.933
Analysis 2 0.391 0.723 -0.336 1.166 7.439 (7) 0.385 0.816 0.056 (0.018, 0.094)
Pooled Analysis 1 0.434 1.913 -0.441 2.302 226.122 (156) \0.001 0.940
Analysis 2 0.567 0.598 -0.368 1.220 24.189 (28) 0.672 0.829 0.056 (0.029, 0.084)
DIF-adjusted 0.520 0.559 -0.356 1.218 33.259 (32) 0.406 0.838
RA Poland Analysis 1 0.142 1.826 -0.556 2.429 151.258 (78) \0.001 0.959
Analysis 2 0.000 1.573 -0.428 1.213 16.953 (14) 0.259 0.894 0.069 (0.034, 0.105)
UK Analysis 1 0.288 1.868 -0.250 2.133 101.958 (39) \0.001 0.932
Analysis 2 0.236 0.953 -3.955 1.290 6.392 (7) 0.495 0.857 0.069 (0.046, 0.143)
Pooled Analysis 1 0.041 2.637 -0.450 2.455 345.946 (117) \0.001 0.954
Analysis 2 -0.003 1.646 -0.440 1.258 28.143 (21) 0.136 0.885 0.067 (0.041, 0.093)
DIF-adjusted 0.163 1.151 -0.441 1.273 28.971 (33) 0.668 0.890
Requirements for perfect fit 0 1 0 1 [0.05 [0.7 Lower-bound 95 %
CI \ 0.05
Analysis 1 preliminary analysis with 39 items, Analysis 2 analysis of subscales (testlets), SD standard deviation, df degrees of freedom,
* p value [ 0.5 for model fit, PSI person separation index
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APerson location [logits]
F-Ratio = 14.339, p = 0.00019
Person location [logits]
F-Ratio = 11.354, p = 0.00087
Person location [logits]
F-Ratio = 20.228, p = 0.00001
Person location [logits]
F-Ratio = 10.702, p = 0.00123
Person location [logits]
F-Ratio = 24.829, p < 0.00001
Key:
x   x   x   x   x   x-- Poland
o   o  o   o   o   o- UK
B
C D
E
Fig. 1 Cross-cultural DIF at domain (testlet) level in the RA and SSc disease groups. RA rheumatoid arthritis, SSc systemic sclerosis. a Pain (RA),
b disease process (RA), c Treatments (RA), d Support (RA), e Support (SSc)
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there is no consensus on the best method for cross-cultural
adaptation [37]. The current adaptation methods either use
a ‘forward–backward’ translation or a ‘forward only’
translation. In this research, we have used the Beaton’s
method [21], which utilizes ‘forward–backward’ transla-
tion. Proponents of a ‘forward only’ approach [38, 39]
suggest that back-translation would cast doubt over the
abilities of the forward translators, producing unmanage-
able amount of text and little information of any value. In
our experience, the ‘forward–backward’ process has been
valuable as evidenced in the results. The expert committee
meeting and a field test with patients ensured thoroughness
in translation, and a conceptual equivalence between the
English and the Polish version of the ENAT was achieved.
It is likely that other methods utilizing a ‘forward–back-
ward’ translation [22–24, 40, 41] would have achieved
similar results.
This study has demonstrated that several items did not
achieve a ‘linguistic equivalence’ or ‘idiomatic equiva-
lence’, and more cultural-specific terms had to be used to
ensure that they are understood by the target population
(Table 2). Even when the adaptation process is successful
to an extent of achieving a linguistic equivalence, this does
not guarantee construct validity and reliability or ‘mea-
surement equivalence’ [26–29]. For this reason, Ku-
cukdeveci et al. [35] have suggested that a psychometric
test of cross-cultural invariance should be incorporated into
the standard adaptation process, so that problematic items
may be reviewed in the translation process.
Subjecting the adapted Pol-ENAT to Rasch analysis
ensured that the measurement properties (construct validity
and reliability) of the ENAT were retained following the
adaptation process. Calibration of the Pol-ENAT into an
interval scale enables transforming the raw data into interval
level for parametric analyses if required. While it is possible
to have a valid and a reliable adapted instrument which works
well in a given culture, when cross-cultural DIF is present, it
means that the instrument works differently at least in some
of the items (or subscales), which possess DIF [27]. Cross-
cultural DIF may mean that the tools are valid for use only in
their respective countries, but not for multinational data
comparisons or data pooling. Alternatively, the tools may
need to be adjusted for the identified cross-cultural DIF to
enable cross-cultural data comparison(s). In this study, Rasch
analysis has confirmed a level of the tools’ cross-cultural
validity sufficient for use between Poland and the UK, and
we have calibrated DIF-adjusted conversion tables for use
where comparison of the Polish and the UK data is required.
This approach has been used in the previous cross-cultural
validation of the ENAT [18, 19] and other questionnaires [35,
42, 43], which are intended for multinational use.
This study has three main limitations. First, convenience
sample was used, and it was obtained from only six centres,
therefore not necessarily representative of the whole Polish
population. This is unlikely however to affect the conclu-
sions of this study since Polish language has no major
variations across the country and sample size requirements
for Rasch analysis were adequately met. Second, the
ENAT is a self-completed questionnaire, and consequently,
it does not reach the population of patients who cannot read
and write. Third, although the ENAT has been validated in
other European countries [19], the DIF-adjusted conversion
table developed in this research applies only to comparison
between Poland and UK data. Comparisons with other
countries can only take place when cross-cultural DIF
patterns between Poland and those countries have been
established. Future research should look into the impact of
the advances in information and communication technol-
ogies and how tools such as Pol-ENAT could go beyond
just assessment of needs, but also link patients with
available and credible resources. Different versions of the
ENAT can be obtained from the University of Leeds by
following this link http://medhealth.leeds.ac.uk/info/732/
psychometric_laboratory/1493/scales.
Conclusion
Using a standard process in cross-cultural adaptation,
conceptual equivalence was achieved between the original
(UK) ENAT and the adapted Pol-ENAT. Fit to the Rasch
model confirmed that the construct validity and internal
consistency of the ENAT have been preserved. The scales
have been calibrated to ensure psychometric equivalence
when undertaking multinational research. The Pol-ENAT
can be used with confidence in assessing the educational
needs of patients with RA and SSc in Poland.
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